Scholarlink

<p> A dual-signal lateral flow immunoassay (LFIA) was developed utilizing gold–platinum core–shell nanoparticles (Au@Pt NPs) for ultrasensitive cardiac troponin I (cTnI) detection. Owing to the synergistic electronic effects between the Au core and dendritic Pt shell, the Au@Pt NPs exhibit both high peroxidase-mimetic activity and a strong near-infrared photothermal effect. This allows for integrated colorimetric amplification and photothermal signal transduction within a single strip format. Under optimized conditions, the assay achieved a visual detection limit of 0.1 ng·mL⁻¹. Quantitative colorimetric determination yield limits of detection (LOD) of 0.044 ng·mL⁻¹ in PBS and 0.051 ng·mL⁻¹ in serum. Notably, the photothermal mode demonstrated exceptional matrix resilience, maintaining nearly identical LODs in PBS (0.036 ng·mL⁻¹) and serum (0.037 ng·mL⁻¹) over a linear range of 0.1–10 ng·mL⁻¹. This matrix-resilient performance is attributed to the thermophysical confinement effect of the biological matrix, which enhances the sensitivity slope in complex media. Overall, the proposed dual-mode LFIA provides a robust, pretreatment-free diagnostic tool that combines rapid visual screening with precise quantitative analysis, supporting early, point-of-care assessment of myocardial injury.</p> Graphical Abstract <p></p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Dual colorimetric-photothermal lateral flow immunoassay based on Au@Pt nanozymes for sensitive detection of cardiac troponin I

  • 期刊论文

  • 发表日期：

    2026年3月29日

查看全文
  • Haoyuan Tan,
  • Xuefeng Cao,
  • Chenchen Xu,
  • Yufan Zhang,
  • Haiyin Li,
  • Hongyuan Yan,
  • Ming Su

摘要

A dual-signal lateral flow immunoassay (LFIA) was developed utilizing gold–platinum core–shell nanoparticles (Au@Pt NPs) for ultrasensitive cardiac troponin I (cTnI) detection. Owing to the synergistic electronic effects between the Au core and dendritic Pt shell, the Au@Pt NPs exhibit both high peroxidase-mimetic activity and a strong near-infrared photothermal effect. This allows for integrated colorimetric amplification and photothermal signal transduction within a single strip format. Under optimized conditions, the assay achieved a visual detection limit of 0.1 ng·mL⁻¹. Quantitative colorimetric determination yield limits of detection (LOD) of 0.044 ng·mL⁻¹ in PBS and 0.051 ng·mL⁻¹ in serum. Notably, the photothermal mode demonstrated exceptional matrix resilience, maintaining nearly identical LODs in PBS (0.036 ng·mL⁻¹) and serum (0.037 ng·mL⁻¹) over a linear range of 0.1–10 ng·mL⁻¹. This matrix-resilient performance is attributed to the thermophysical confinement effect of the biological matrix, which enhances the sensitivity slope in complex media. Overall, the proposed dual-mode LFIA provides a robust, pretreatment-free diagnostic tool that combines rapid visual screening with precise quantitative analysis, supporting early, point-of-care assessment of myocardial injury.

Graphical Abstract